Most Popular Stories
- Hospitals lose reimbursement for 'unnecessary' ER visits
- Healthcare jobs will grow the fastest of all industries
- Online tools, social media ease clinical recruiting, research
- Hospital exec arrested in $116M Medicare scheme
- Medicaid cuts loom despite overdue reimbursements
- Docs not always honest with patients
Featured Jobs
-
Electronic Health Records Application Support Manager RN-New Year New Career
Avanti on behalf of Respected Health System - San Francisco, CA -
Epic Ambulatory Beacon Consultant
Meditology Services - NC -
ICD-10 Revenue Cycle, Manager
Meditology Services - Atlanta, GA
Events
- IHI's Breakthrough Series College
April 11-13, 2012 — Cambridge, MA - ICD-10 Reality Check - Breakfast Panel at HiMSS 2012!
February 22, 2012 - From IHI: The Patient Experience Seminar
March 27-28 — Boston, MA - CIO Healthcare Summit
March 11-14 — Scottsdale, AZ
Paid Research Reports
- Electronic health records: getting it right first time
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Stakeholder Opinions: Ophthalmology - Leading brands under threat
- Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
- Healthcare Regulatory Update: The United Arab Emirates
- Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
Merck's position seen as tenuous
August 18, 2005 — 7:01pm ET
Tools
As jurors in Texas weigh the company's fate, executives at Merck are considering a sobering reality. Even if Merck does manage to win the lawsuit against it over the role of the painkiller Vioxx in the death of Peter Ernst, the company still faces thousands of other suits making similar charges. Going into Ernst v. Merck, many legal experts had predicted an easy win for Merck. It hasn't quite worked out that way. Many say Houston attorney W. Mark Lanier may have pulled off a major legal triumph.
- see this story from the Boston Globe
SHARE WITH:
Related Stories
- Lanier 'Dream Team' to file thousands of new Vioxx claims
- Vioxx lawsuits continue to multiply
- GAO report details problems at FDA
- Gilmartin testifies in Vioxx suit
- Vioxx verdict shocks markets
- Fourth Vioxx trial begins
- SPOTLIGHT: Scientists stand by Vioxx research
- Merck scores victory in second Vioxx trial
- SPOTLIGHT: A little pain relief for Merck
- Second Vioxx trial opens in NJ
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map
| Editors | List in Marketplace | Supplier in MarketplaceTHE FIERCEMARKETS NETWORKFierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2011 FierceMarkets. All rights reserved. |
![]() |
